Differences in immune responses to antibiotics in three guinea-pig strains.

Aida, Tetsuo; Ishikawa, N; Shinkai, Kenkichi

doi:10.2131/jts.22.5_439

Cited by 4 publications

(1 citation statement)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This preclinical study was conducted according to good laboratory practice (GLP) regulations. The second experiment includes examination of Hartley guinea pigs, which are used widely for immunogenicity studies , to evaluate the absence of active systemic anaphylaxis (ASA) and passive cutaneous anaphylaxis (PCA), to scrutinize the immunogenicity profile of PEGylated liposomes used for HbV.…”

Section: Introductionmentioning

confidence: 99%

Absence of Anaphylactic Reactions to Injection of Hemoglobin Vesicles (Artificial Red Cells) to Rodents

Sakai,

Kure,

Kobayashi

et al. 2023

ACS Omega

View full text Add to dashboard Cite

The safety and efficacy of hemoglobin vesicles (HbVs) as artificial oxygen carriers encapsulating a purified and concentrated Hb solution in liposomes have been studied extensively. The HbV surface, modified with PEG by incorporating a PEG-conjugated phospholipid, is beneficial for storage and biocompatibility. However, it might be possible that interaction of PEG and the pre-existing anti-PEG antibody in the bloodstream causes acute adverse reaction. This study used two sets of experiments with rats and guinea pigs to ascertain whether the anti-PEG antibody generated by the PEG-modified HbV injection can induce anaphylactic reactions. SD rats received repeated intravenous injection of HbV at a dose rate of 16 or 32 mL/kg three times. Not anti-PEG IgG but anti-PEG IgM was detected. Nevertheless, no anaphylactic reaction occurred. Guinea pigs were used to study the presence of active systemic anaphylaxis further after injections of the PEG-modified liposomes used for HbV. The animals were sensitized by three repeated subcutaneous injections of PEG-modified liposomes (PEG–liposome) along with adjuvant at 1 week intervals. For comparison, unmodified liposomes (liposome) and 10 times excessively PEG-modified liposomes with ionizable lipid (10PEG–DODAP–liposome) were used. Inclusion of PEG modification induced not only anti-PEG IgM but also anti-PEG IgG. Three weeks after the final injection, intravenous injection of both PEG–liposome and liposome (1 mL/kg) induced no anaphylactic reaction. However, the injection of 10PEG–DODAP–liposome showed one lethal anaphylaxis case and one mild anaphylaxis case. Antisera obtained from the animal sensitized as described above were inoculated (0.05 mL) intradermally into fresh guinea pigs. The presence of passive cutaneous anaphylaxis was evaluated after intravenous injections (1 mL/kg) of three liposomes with Evans blue. No dye leakage was detected at any inoculated skin point for PEG–liposome or liposome, but a slight leakage was detected in one inoculated skin point for 10PEG–DODAP–liposome. These results indicate the absence of acute allergic reactions at repeated injections of HbVs despite the anti-PEG antibody induction. Not all the PEG-modified liposomes show anaphylaxis, and it may depend on the amount of PEGylated phospholipid and lipid composition of PEG-modified liposomes.

show abstract

Section: Introductionmentioning

confidence: 99%